Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 9/20 | 0.59 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.59 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.59 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.55 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | DRD5 | P21918 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | FABP4 | P15090 | 2/20 | 0.31 |
| ▸ | FABP3 | P05413 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7960526 | 0.88 | PTGIR (0.60) | PTGIRPTGER4PTGER1PTGER3DRD2 | |
| SCHEMBL7964274 | 0.87 | PTGIR (0.54) | PTGIRPTGER4PTGER1PTGER3PPARD | |
| SCHEMBL7479528 | 0.87 | PTGIR (0.69) | PTGIRPTGER4PTGER1PTGER3DRD2 | |
| SCHEMBL7479534 | 0.87 | PTGIR (0.69) | PTGIRPTGER4PTGER1PTGER3DRD2 | |
| SCHEMBL7949627 | 0.87 | PTGIR (0.69) | PTGIRPTGER4PTGER1PTGER3DRD2 | |
| SCHEMBL7475683 | 0.87 | PTGIR (0.62) | PTGIRPTGER4PTGER1PTGER3DRD2 | |
| SCHEMBL7490153 | 0.87 | PTGIR (0.64) | PTGIRPTGER4PTGER1PTGER3PPARD | |
| SCHEMBL7949681 | 0.86 | PTGIR (0.58) | PTGIRPTGER4PTGER1PTGER3PTGS2 | |
| SCHEMBL7960041 | 0.86 | PTGER4 (0.56) | PTGIRPTGER4PTGER1PTGER3DRD2 | |
| SCHEMBL7964160 | 0.85 | PTGIR (0.54) | PTGIRPTGER4PTGER1PTGER3DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6245790-B1 | ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-12 | — | — | US | disclosed |
| EP-0989975-A1 | OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-05 | — | — | EP | disclosed |
| WO-2000016760-A2 | NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-03-30 | — | — | WO | disclosed |
| WO-1998055468-A1 | OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-12-10 | — | — | WO | disclosed |